Hazardous waste: Whatâs so âSpecialâ? Mark Heggie Waste Policy Unit [email protected] Regulatory framework What is it, how is it regulated and what are our duties/responsibilities…
making investor presentations 03/09/2012 1 MAS 6v04 - S04 - Case: Active Coatings, Inc. (A) 03/09/2012 (c) 2003 Joseph C. Picken 1 FTF Pharma Ltd. Your partner of choice…
Drug Delivery and Generic Medicine The Challenge ahead; Choose where to play. MENA as an Industry Model Mohammad Refaat Khattab Cairo University; Egypt World Drug Delivery…
Trends & Challenges - Generic Drug Business in Malaysia David Ho Managing Director Hovid Bhd, Malaysia Focus of Presentation Overview of the pharmaceutical business Trends…
DNDi Pediatric HIV Program: A draft plan for consultation with Dr. Hamid Rachel Cohen, Regional Executive Director, DNDi North America Proposals for a Global Innovation System…
Bedeutung der Pharmaindustrie für die Schweiz Pharmaceuticals and Global Health: Successes, Challenges and Outlook 19. July 2013, University of Sussex Thomas B. Cueni,…
The essence of global pharmaceutical marketing Definitions of marketing âMarketing is the management process that identifies, anticipates and satisfies customer requirements…
1 Generics in Japan Evolving pricing, regulatory, and business environments Reference Code: BI00050-008 Publication Date: January 2012 2 About the author Donald Macarthur…
Main changes in the pharmaceutical industry Limited number of new molecules in R&D pipelines (except some “me too” molecules)=> lack of fundamental innovation/patent…